Cargando…
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
There is limited knowledge about the metabolic reprogramming induced by cancer therapies and how this contributes to therapeutic resistance. Here we show that although inhibition of PI3K–AKT–mTOR signaling markedly decreased glycolysis and restrained tumor growth, these signaling and metabolic restr...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733498/ https://www.ncbi.nlm.nih.gov/pubmed/29138276 http://dx.doi.org/10.1101/gad.305292.117 |
_version_ | 1783286913881341952 |
---|---|
author | Lue, Hui-wen Podolak, Jennifer Kolahi, Kevin Cheng, Larry Rao, Soumya Garg, Devin Xue, Chang-Hui Rantala, Juha K. Tyner, Jeffrey W. Thornburg, Kent L. Martinez-Acevedo, Ann Liu, Jen-Jane Amling, Christopher L. Truillet, Charles Louie, Sharon M. Anderson, Kimberly E. Evans, Michael J. O'Donnell, Valerie B. Nomura, Daniel K. Drake, Justin M. Ritz, Anna Thomas, George V. |
author_facet | Lue, Hui-wen Podolak, Jennifer Kolahi, Kevin Cheng, Larry Rao, Soumya Garg, Devin Xue, Chang-Hui Rantala, Juha K. Tyner, Jeffrey W. Thornburg, Kent L. Martinez-Acevedo, Ann Liu, Jen-Jane Amling, Christopher L. Truillet, Charles Louie, Sharon M. Anderson, Kimberly E. Evans, Michael J. O'Donnell, Valerie B. Nomura, Daniel K. Drake, Justin M. Ritz, Anna Thomas, George V. |
author_sort | Lue, Hui-wen |
collection | PubMed |
description | There is limited knowledge about the metabolic reprogramming induced by cancer therapies and how this contributes to therapeutic resistance. Here we show that although inhibition of PI3K–AKT–mTOR signaling markedly decreased glycolysis and restrained tumor growth, these signaling and metabolic restrictions triggered autophagy, which supplied the metabolites required for the maintenance of mitochondrial respiration and redox homeostasis. Specifically, we found that survival of cancer cells was critically dependent on phospholipase A2 (PLA2) to mobilize lysophospholipids and free fatty acids to sustain fatty acid oxidation and oxidative phosphorylation. Consistent with this, we observed significantly increased lipid droplets, with subsequent mobilization to mitochondria. These changes were abrogated in cells deficient for the essential autophagy gene ATG5. Accordingly, inhibition of PLA2 significantly decreased lipid droplets, decreased oxidative phosphorylation, and increased apoptosis. Together, these results describe how treatment-induced autophagy provides nutrients for cancer cell survival and identifies novel cotreatment strategies to override this survival advantage. |
format | Online Article Text |
id | pubmed-5733498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57334982018-04-15 Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade Lue, Hui-wen Podolak, Jennifer Kolahi, Kevin Cheng, Larry Rao, Soumya Garg, Devin Xue, Chang-Hui Rantala, Juha K. Tyner, Jeffrey W. Thornburg, Kent L. Martinez-Acevedo, Ann Liu, Jen-Jane Amling, Christopher L. Truillet, Charles Louie, Sharon M. Anderson, Kimberly E. Evans, Michael J. O'Donnell, Valerie B. Nomura, Daniel K. Drake, Justin M. Ritz, Anna Thomas, George V. Genes Dev Research Paper There is limited knowledge about the metabolic reprogramming induced by cancer therapies and how this contributes to therapeutic resistance. Here we show that although inhibition of PI3K–AKT–mTOR signaling markedly decreased glycolysis and restrained tumor growth, these signaling and metabolic restrictions triggered autophagy, which supplied the metabolites required for the maintenance of mitochondrial respiration and redox homeostasis. Specifically, we found that survival of cancer cells was critically dependent on phospholipase A2 (PLA2) to mobilize lysophospholipids and free fatty acids to sustain fatty acid oxidation and oxidative phosphorylation. Consistent with this, we observed significantly increased lipid droplets, with subsequent mobilization to mitochondria. These changes were abrogated in cells deficient for the essential autophagy gene ATG5. Accordingly, inhibition of PLA2 significantly decreased lipid droplets, decreased oxidative phosphorylation, and increased apoptosis. Together, these results describe how treatment-induced autophagy provides nutrients for cancer cell survival and identifies novel cotreatment strategies to override this survival advantage. Cold Spring Harbor Laboratory Press 2017-10-15 /pmc/articles/PMC5733498/ /pubmed/29138276 http://dx.doi.org/10.1101/gad.305292.117 Text en © 2017 Lue et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Paper Lue, Hui-wen Podolak, Jennifer Kolahi, Kevin Cheng, Larry Rao, Soumya Garg, Devin Xue, Chang-Hui Rantala, Juha K. Tyner, Jeffrey W. Thornburg, Kent L. Martinez-Acevedo, Ann Liu, Jen-Jane Amling, Christopher L. Truillet, Charles Louie, Sharon M. Anderson, Kimberly E. Evans, Michael J. O'Donnell, Valerie B. Nomura, Daniel K. Drake, Justin M. Ritz, Anna Thomas, George V. Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title | Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title_full | Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title_fullStr | Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title_full_unstemmed | Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title_short | Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
title_sort | metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733498/ https://www.ncbi.nlm.nih.gov/pubmed/29138276 http://dx.doi.org/10.1101/gad.305292.117 |
work_keys_str_mv | AT luehuiwen metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT podolakjennifer metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT kolahikevin metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT chenglarry metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT raosoumya metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT gargdevin metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT xuechanghui metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT rantalajuhak metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT tynerjeffreyw metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT thornburgkentl metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT martinezacevedoann metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT liujenjane metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT amlingchristopherl metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT truilletcharles metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT louiesharonm metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT andersonkimberlye metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT evansmichaelj metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT odonnellvalerieb metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT nomuradanielk metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT drakejustinm metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT ritzanna metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade AT thomasgeorgev metabolicreprogrammingensurescancercellsurvivaldespiteoncogenicsignalingblockade |